NCT00892177 2019-10-21Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma MultiformeAlliance for Clinical Trials in OncologyPhase 2 Completed144 enrolled 14 charts